Marinus Pharmaceuticals, Inc. (MRNS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 146.19M |
| Enterprise Value | 135.98M |
| P/E Ratio | -0.21 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0.98 |
| Price/Book Ratio | 1.76 |
| Enterprise/Revenue | 0.65 |
| Enterprise/EBITDA | -0.16 |
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | September 30, 2024 |
| Profit Margin | -4.56 |
| Operating Margin | -4.24 |
| Return On Assets | -0.83 |
| Return On Equity | -2.13 |
| Revenue | 30.99M |
| Revenue/Share | 0.58 |
| Gross Profit | 29.06M |
| EBITDA | -125.5M |
| Net Income | -141.41M |
| Diluted EPS | -2.63 |
| Total Cash | 42.18M |
| Total Cash/Share | 2.8 |
| Total Debt | 55.99M |
| Total Debt/Equity | 6.58 |
| Current Ratio | 4.07 |
| Book Value Per Share | 0.31 |
| 52-Week Change | -76.29 |
| 52-Week High | 10.5 |
| 52-Week Low | 0.22 |
| Moving Average 50 Days | 0.43 |
| Moving Average 200 Days | 1.06 |
| Average Volume | 1.81M |
| Shares Outstanding | 55.22M |
| % Held by Institutions | 0.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | September 23, 2020 |